Sistema de Salut de Catalunya
Institut Català de la Salut
[Garrido P] Universidad de Alcalá, Medical Oncology Department, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Adjei AA] Mayo Clinic, Rochester, USA. [Bajpai J] Tata Memorial Centre, Mumbai, India. [Banerjee S] The Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK. [Berghoff AS] Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria. [Choo SP] Curie Oncology Singapore, National Cancer Centre Singapore, Singapore. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Thoracic Oncology and H&N Cancer Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain. [Garralda E] Early Drug Development Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2022-02-23T06:49:57Z
2022-02-23T06:49:57Z
2021-06
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Desigualtats; Dona
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Desigualdades; Mujer
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV Inequalities; Woman
Background European Society for Medical Oncology Women for Oncology (ESMO W4O) research has previously shown under-representation of female oncologists in leadership roles. As early reports suggested disproportionate effects of the COVID-19 pandemic on women, the ESMO W4O Committee initiated a study on the impact of the pandemic on the lives of female and male oncologists. Methods A questionnaire was sent to ESMO members and put on the ESMO website between 8 June 2020 and 2 July 2020. Questions focused on the working (hospital tasks, laboratory tasks, science) and home (household management, childcare, parent care, personal care) lives of oncologists during and after COVID-19-related lockdowns. Results Of 649 respondents, 541 completed the questionnaire. Of these, 58% reported that COVID-19 had affected their professional career, 83% of whom said this was in a negative way (85% of women versus 76% of men). Approximately 86% reported that COVID-19 had changed their personal life and 82% their family life. Women were again significantly more affected than men: personal life (89% versus 78%; P = 0.001); family life (84% versus 77%; P = 0.037). During lockdowns, women reported increased time spent on hospital and laboratory tasks compared with men (53% versus 46% and 33% versus 26%, respectively) and a significantly higher proportion of women than men spent less time on science (39% versus 25%) and personal care (58% versus 39%). After confinement, this trend remained for science (42% versus 23%) and personal care (55% versus 36%). Conclusions The COVID-19 pandemic has adversely affected the professional and home lives of oncologists, especially women. Reduced research time for female oncologists may have long-lasting career consequences, especially for those at key stages in their career. The gender gap for promotion to leadership positions may widen further as a result of the pandemic.
This work was supported by the European Society for Medical Oncology (ESMO).
Article
Published version
English
Pandèmia de COVID-19, 2020-; Oncologia; Qüestionaris; DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections; NAMED GROUPS::Persons::Occupational Groups::Health Personnel::Physicians::Oncologists; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus; DENOMINACIONES DE GRUPOS::personas::grupos profesionales::personal sanitario::médicos::oncólogos; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios
Elsevier
ESMO Open;6(3)
https://doi.org/10.1016/j.esmoop.2021.100131
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3439]
